Key Stats for Altria Stock
- 52-Week Range: $54.70 to $77.06
- Street Mean Target: $70.00
- Dividend Yield: 6.4%
- NTM P/E: ~12x
- YTD Return: +21%
- LTM EBIT Margin: 76.0%
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
Why Altria Keeps Growing Earnings Even as Fewer Americans Smoke
Altria Group (MO) is one of the most straightforward businesses in the public markets to understand and one of the most debated to own. The company makes and sells cigarettes in the United States, primarily through its Marlboro brand, which has held a dominant share of the premium segment for decades. Cigarette volumes are in structural decline, and that is undisputed.
Over many years, Altria has shown that pricing power, operating discipline, and aggressive capital return can more than offset that volume pressure, producing a business that keeps growing earnings and dividends even as fewer Americans smoke. The stock is up roughly 21% year-to-date, and the 6.4% dividend yield remains one of the highest available anywhere in the large-cap universe.
Second-quarter adjusted diluted EPS grew 4.9% year over year, and Altria narrowed its full-year guidance to a range of $5.61 to $5.68. Revenue net of excise taxes grew 3.1% to $5.1 billion in the quarter.
Smokeable products volume declined 2.8%, consistent with the industry’s long-term trend, but Marlboro’s share of the premium cigarette segment held at 59.6%, reflecting the brand’s enduring pricing power.
The mechanism is not complicated: raise prices by more than enough to offset the volume loss, keep costs controlled, buy back shares steadily, and pass the resulting cash to shareholders. The EPS chart below shows how consistently that has played out.
EPS has grown every single year since 2021, rising from $4.61 to $5.42 by the end of 2025 with no interruptions, and consensus estimates project continued growth toward $5.68 this year and $6.45 by 2030.
There are no dips in the chart, no years of earnings compression, just steady compounding driven by price increases and share count reduction. It is a track record that is genuinely difficult to dismiss, and it is the primary reason long-term holders rarely feel the urge to sell.
See how Altria’s dividend and growth assumptions drive its target price (It’s free) >>>
The Free Cash Flow Engine That Makes the Dividend So Dependable
The dividend, currently yielding around 6.4%, is the other half of the Altria investment case, and the free cash flow chart below explains why the payout is so well supported.
Free cash flow has held between roughly $8.0 billion and $9.1 billion every year since 2021, one of the most stable FCF profiles in the large-cap market. The consistency reflects a business with almost no capital intensity, minimal reinvestment requirements, and an 87% gross margin that converts revenue into cash at a rate most industries cannot approach.
The payout ratio sits near 89%, which looks high in isolation but is entirely sustainable given the FCF generation and the slow, predictable pace of earnings growth. Altria has raised its dividend for more than 50 consecutive years, and nothing in the current financial picture suggests that streak is at risk.
Beyond cigarettes, the company has been investing in smoke-free alternatives: NJOY e-vapor is now in roughly 100,000 retail stores nationwide, and on! Nicotine pouches are gaining share in the oral tobacco category, adding optionality that the market is only beginning to price in.
See how Altria performs against its peers in TIKR (It’s free!) >>>
What Does the Valuation Model Say?
At around $68, Altria trades at roughly 12 times forward earnings. The TIKR mid-case model targets around $90 per share by the end of 2030, implying a total return of roughly 31% from price appreciation alone, or around 6% annualized.
Add the 6.4% dividend yield on top, and the total annual return picture becomes considerably more attractive for income-oriented investors.
The mid case assumes revenue growing around 3% per year and net income margins expanding toward 47%, both consistent with the company’s historical trajectory.
Should You Buy Altria Stock?
Altria is not a growth stock, and no serious investor should approach it as one. The cigarette volume decline is real and will continue, regulatory risk around nicotine products remains, and the company’s long-term future depends on whether the smoke-free transition gains enough traction to offset what the core business loses over time.
For income investors, the combination of a 6.4% yield, consistent EPS growth, and a half-century track record of dividend increases is genuinely hard to replicate elsewhere.
The Street’s mean target of $70 implies the stock is roughly fairly valued on price alone, but investors buying for total return rather than price appreciation have a more compelling case to make.
See analysts’ growth forecasts and price targets for Altria stock (It’s free!) >>>
Looking for New Opportunities?
- See which stocks billionaire investors are buying to follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!
